EMCDDA Document Library

  Filter by
 

Filter by origin:

Publication date

Category

Main subject

Keywords

Geographical scope

Document language

Displaying 1 - 6 of 6
no image available

HCV prevalence and risk behaviours among injectors of new psychoactive substances in a risk environment in Hungary-An expanding public health burden

December 2016

In Hungary a large increase in injecting new psychoactive substances (NPS) coincided with decreasing harm reduction efforts and rising HCV infection. NPS injectors in Hungary are at severe risk of blood-borne infections due to high levels of injecting and sexual risk behaviours within a high-risk...
no image available

Addressing barriers to the prevention, diagnosis and treatment of hepatitis B and C in the face of persisting fiscal constraints in Europe: report from a high level conference

January 2016

In June 2014 the Athens High Level Meeting discussed recent policy developments, persisting and emerging challenges related to the prevention and management of viral hepatitis and the need for a de minimis framework of urgent priorities for action.
no image available

Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening

April 2013

The prevalence of chronic HBV and HCV infection varies widely between European countries. Cost-effectiveness analyses may need to take effect of antiviral treatment on preventing HBV and HCV transmission.
document cover

Public expenditure on drugs in the European Union 2000–2004

October 2004

This report summarises the available data and figures on expenditure in the field of drugs in the EU and Norway. While some studies in the peer-reviewed literature were found (Finland, France, Spain and the UK) and extensive reports exist for Austria, Belgium, France and the UK, further, data had...
document cover

Public spending on drugs in the European Union during the 1990s: retrospective research

April 2003

This retrospective study presents an overview of drug-related public expenditure engaged by the countries of the European Union during the decade 1990–2000. The aim of the research was to collect at EU level existing figures on public expenditure in the field of drugs, what is usually called ‘the...
publication cover

European Network to Develop Policy Relevant Models and Socio-Economic Analyses of Drug Use, Consequences and Interventions Final report: Part 6 – Costs and Cost effectiveness of Interventions

January 2002

The global aims of the present project concern: (1) the estimation of costs for society of problem drug use, and (2) the assessment of the cost-effectiveness of different forms of intervention using models. The main questions explored by the project are: what is the cost-of-illness related to...